Physician profile
John M Compoginis
NPI 1306039318
$1,588.17
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $80.49 · 2021: $72.93 · 2022: $782 · 2023: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400 · Food and Beverage: $77.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
| Food and Beverage | $77.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $651.08 | 2021-2022 | |
| Avita Medical Americas, LLC | $400.00 | 2023 | Recell |
| Tela Bio, INC. | $248.57 | 2019-2022 | |
| Mentor Worldwide LLC | $67.34 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $61.87 | 2021-2022 | |
| Acell, INC. | $57.20 | 2020 | |
| Abbvie INC. | $29.30 | 2023 | Botox |
| Avanos Medical | $22.43 | 2023 | On-Q* Pump and Accessories |
| Allergan, INC. | $22.03 | 2022 | |
| Polynovo North America LLC | $14.85 | 2021 | |
| Depuy Synthes Sales INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Compoginis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.